title: Successful treatment continuation with a single mild partial splenic embolization for thrombocytopenia caused by oxaliplatin-based chemotherapy for advanced colon cancer.
abstract: We report the case of a patient with advanced colon cancer receiving oxaliplatin-based chemotherapy that was able to continue systemic chemotherapy by performing mild partial splenic embolization (PSE) for thrombocytopenia caused by splenomegaly due to oxaliplatin. Mild PSE may be useful for thrombocytopenia due to splenomegaly in cancer patients because it provides more treatment opportunities.
authors.affiliation: Department of Radiology, Graduate School of Medical Science, University of the Ryukyus, 207, Uehara, Nishihara, Okinawa, 903-0215, Japan. anna1150@med.u-ryukyu.ac.jp.
authors.forename: Joichi
authors.initials: J
authors.lastname: Heianna
authors.affiliation: Department of Clinical Oncology, Akita Red Cross Hospital, 222-1, Kamikitate, Saruta, Akita City, 010-1406, Japan.
authors.forename: Osamu
authors.initials: O
authors.lastname: Muto
authors.affiliation: Department of Radiology, Akita Red Cross Hospital, 222-1, Kamikitate, Saruta, Akita City, 010-1406, Japan.
authors.forename: Takaharu
authors.initials: T
authors.lastname: Miyauchi
authors.affiliation: Department of Radiology, Akita Red Cross Hospital, 222-1, Kamikitate, Saruta, Akita City, 010-1406, Japan.
authors.forename: Wataru
authors.initials: W
authors.lastname: Endo
authors.affiliation: Department of Radiology, Akita Red Cross Hospital, 222-1, Kamikitate, Saruta, Akita City, 010-1406, Japan.
authors.forename: Aki
authors.initials: A
authors.lastname: Togashi
authors.affiliation: Department of Radiology, Graduate School of Medical Science, University of the Ryukyus, 207, Uehara, Nishihara, Okinawa, 903-0215, Japan.
authors.forename: Kimei
authors.initials: K
authors.lastname: Azama
authors.affiliation: Department of Radiology, Graduate School of Medical Science, University of the Ryukyus, 207, Uehara, Nishihara, Okinawa, 903-0215, Japan.
authors.forename: Sadayuki
authors.initials: S
authors.lastname: Murayama
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use*; D003110:Colonic Neoplasms / Q000188:drug therapy*; D004621:Embolization, Therapeutic / Q000379:methods*; D005260:Female; D006801:Humans; D009944:Organoplatinum Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D000077150:Oxaliplatin; D013154:Spleen; D013163:Splenomegaly / Q000139:chemically induced; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000628:therapy*; D016896:Treatment Outcome
chemical_list: D009944:Organoplatinum Compounds; D000077150:Oxaliplatin
keywords: Colon cancer; Oxaliplatin; Partial splenic embolization; Splenomegaly; Thrombocytopenia